Excited to be at #ASCO23 ! Stop by booth 28111 to chat with a member of the Haystack team. We're ready to answer your #MRDtesting questions. #PrecisionOncology

Detecting residual diseases just got better! Haystack MRD optimizes sensitivity by finding the right balance between DNA input and mutations tracked. Learn more about this revolutionary approach: hubs.la/Q02h-n690 #MRDtesting #PrecisionMedicine

Haystack MRD™ enables oncologists to catch even the smallest traces of cancer cells and provide more personalized treatment to detect early cancer recurrence. This is a game-changing technology for cancer care. Learn more at hubs.la/Q01DQTck0

#CancerCare #MRDtesting

Haystack MRD™ can improve outcomes for solid tumor cancer patients by providing valuable information about a patient's risk of recurrence earlier than other methods. Learn more at hubs.la/Q021Qqws0 #MRDtesting #PrecisionOncology

Day +56. #BoneMarrowBiopsy today & first myeloma testing post #transplant ! #MRDTesting #mrdNEGATIVE 🤞🤞🤞

Don't miss our poster presentation at #ISMRC2023 with SensID! Discover how our ultra-sensitive #MRD test enables the characterization of cell-free DNA with high sensitivity and accuracy. Learn more at hubs.la/Q01LwLdx0 #MRD testing #oncologyresearch

The treatment options may not be endless, but the opportunity for shared decision-making is. #MRDtesting
clonoSEQ is FDA-cleared to assess MRD in patients with CLL, MM, or B-ALL. For important info, incl. sample types & test limitations: rb.gy/8tju9y

LymphoTrack® MRD Bundled Solution includes LymphoTrack Assay kit for Ig gene targets, LymphoQuant® B-cell Internal Control, LymphoTrack B-cell Low Positive Control. For more info please contact [email protected] #mrdtesting #bioinformatics #genomics #allianceglobal

#Phycisians #Advocates #Patients & more. Interested in hearing more about #MRDTesting ? Our Dr. Dan is moderating the MRD Testing Collaborative, a panel discussion changes to MRD testing. Register today hhealth.zoom.us/webinar/regist…

Dive into the world of Measurable Residual Disease ( #MRD ) testing for hematologic malignancies! 🩸Complete this #CME activity led by Dr. Noopur Raje, here: bit.ly/49v2Vbq

#CancerCare #MRD Testing #Hematology #MedicalEducation #Physician

'If you're not doing #MRDtesting , you're missing out on the joy of your clinical practice. Being able to tell that to a patient is incredibly rewarding...'

Hear more great insight from Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 in our latest CANCER BUZZ #podcast : bit.ly/3JQoyX3

Were you diagnosed with Multiple Myeloma or ALL? Take our #MRDTesting survey about Minimal Residual Disease (MRD).

Awareness is critical. Together we can all make a difference: grythealth.typeform.com/to/nVD3uv

Exciting news in MRD testing! Find out how Haystack MRD strikes the perfect balance between DNA input and mutations tracked for optimal efficiency and sustainability. Read the blog post: hubs.la/Q01R5KNl0 #MRDtesting #PrecisionMedicine

The Rise of MRD Testing and the Field of Fragmentomics with Sugganth Daniel, Director of Oncology Medical Affairs Invitae
buff.ly/3icjfVL
#MRDtesting #cancergenomics #cellfreeDNA #Fragmentomics

Calling all physicians and patient advocacy groups! Interested in hearing more about #MRDTesting ? Join the MRD Testing Collaborative for a panel discussion on the clinical utility of MRD & how COVID has impacted diagnosis & treatment of #bloodcancers . bit.ly/3GJbXma

Largest Study of Its Kind Shows ctDNA to Be Highly Predictive in Cancer Patients: Alex Aleshin, Luis Natera, Ph.D.
buff.ly/3kjqGvd
#ctDNA #cancergenomics #MRDtesting Alexey Aleshin

Great session this evening of the MRD collaborative this evening with a panel discussion of @DaveFuehrer Gryt Health CLL Society Inc. The Leukemia & Lymphoma Society Stupid Cancer and myself

So important for patients and so much work to do #EHA24

#AmIUndetectable #MRDtesting #undetectable #BeMRDaware

#MRDtesting

Join the MRD Testing Collaborative for a panel discussion for #physicians and patient organisations on the clinical utility of MRD testing and how COVID has impacted diagnosis and treatment of #bloodcancers . Register for free today: bit.ly/3GJbXma

Growing evidence suggesting NGS based MRD monitoring post alloHCT predicts outcome. However, most insurance company deny reimbursement of such testing. We need to lobby against these denials. #AML #MRDtesting #leusm

Nicole Rochester, MD hosts this Patient Empowerment Network program as expert Christian Rolfo from Mount Sinai Health System, discusses how #MRDtesting aids in patient monitoring, the use of liquid biopsies in patient care, and updates about immunotherapy for early stage #lungcancer .

ow.ly/kFaO50L5tNH